BBI Insider Trading

Insider Ownership Percentage: 4.53%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Brickell Biotech Insider Trading History Chart

This chart shows the insider buying and selling history at Brickell Biotech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Brickell Biotech Share Price & Price History

Current Price: $1.85
Price Change: Price Decrease of -0.02 (-1.07%)
As of 09/26/2022 01:00 AM ET

This chart shows the closing price history over time for BBI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Brickell Biotech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/26/2021Reginald L HardyChairmanBuy100,000$0.67$67,000.00View SEC Filing Icon  
7/23/2021David R. McavoyGeneral CounselBuy18,124$0.67$12,143.08128,879View SEC Filing Icon  
7/23/2021Reginald L. HardyChairmanBuy100,000$0.66$66,000.00348,411View SEC Filing Icon  
5/18/2021Deepak ChadhaInsiderBuy2,700$0.82$2,214.0065,667View SEC Filing Icon  
5/17/2021Andrew D. SklawerCOOBuy15,375$0.80$12,300.00124,625View SEC Filing Icon  
5/17/2021David R. McAvoyGeneral CounselBuy18,622$0.80$14,897.60110,755View SEC Filing Icon  
3/15/2021Robert Busard BrownCEOBuy100,000$1.18$118,000.00186,957View SEC Filing Icon  
9/18/2020David R. McAvoyGeneral CounselBuy22,526$0.83$18,696.5875,883View SEC Filing Icon  
9/15/2020Dennison T VeruDirectorBuy15,355$0.81$12,437.557,230View SEC Filing Icon  
See Full Table
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast
He predicted the 2020 crash a month before it happened…He predicted this year’s collapse back in January…

And now, he’s issuing a brand-new warning – along with a unique solution.
Details here.

SEC Filings (Institutional Ownership Changes) for Brickell Biotech (NASDAQ:BBI)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BBI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Brickell Biotech Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2022Millennium Management LLC500,736$63K0.0%N/A18.889%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC1,419,552$0.38M0.0%-53.2%1.189%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.3,112,092$0.83M0.0%+14.8%2.607%Search for SEC Filing on Google Icon
11/16/2021Telemetry Investments L.L.C.699,338$0.50M0.7%+14.6%0.608%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP248,693$0.18M0.0%N/A0.216%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC1,377,804$0.99M0.0%-9.3%1.198%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.63,544$46K0.0%+69.2%0.055%Search for SEC Filing on Google Icon
11/5/2021Smith Salley & Associates44,380$32K0.0%-88.3%0.050%Search for SEC Filing on Google Icon
8/16/2021Telemetry Investments L.L.C.609,993$0.58M0.8%+18.9%0.718%Search for SEC Filing on Google Icon
8/16/2021State Street Corp60,847$58K0.0%N/A0.072%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC1,519,027$1.45M0.0%+41.1%1.789%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC563,312$0.54M0.0%+5.7%0.663%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.2,601,358$2.48M0.0%+49.7%3.063%Search for SEC Filing on Google Icon
8/9/2021Smith Salley & Associates379,167$0.36M0.0%+754.4%0.446%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC65,605$72K0.0%+242.0%0.098%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP27,407$29K0.0%N/A0.041%Search for SEC Filing on Google Icon
5/17/2021Thrivent Financial for Lutherans52,134$57K0.0%+139.6%0.078%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC1,076,537$1.17M0.0%+22.6%1.608%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp60,367$66K0.0%N/A0.090%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC533,127$0.58M0.0%+166.6%0.797%Search for SEC Filing on Google Icon
5/7/2021Fifth Third Bancorp25,000$27K0.0%N/A0.037%Search for SEC Filing on Google Icon
4/30/2021Smith Salley & Associates44,380$48K0.0%+271.5%0.066%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC83,783$65K0.0%N/A0.157%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC877,986$0.69M0.0%+42.0%1.641%Search for SEC Filing on Google Icon
8/12/2020Goldman Sachs Group Inc.74,277$74K0.0%N/A0.304%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Brickell Biotech logo
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.
Read More on Brickell Biotech

Today's Range

Now: $1.85
Low: $1.81
High: $1.90

50 Day Range

MA: $2.80
Low: $1.82
High: $4.19

52 Week Range

Now: $1.85
Low: $2.21
High: $37.35

Volume

19,795 shs

Average Volume

206,730 shs

Market Capitalization

$5.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.02

Who are the company insiders with the largest holdings of Brickell Biotech?

Brickell Biotech's top insider investors include:
  1. Reginald L Hardy (Chairman)
  2. Robert Busard Brown (CEO)
  3. David R Mcavoy (General Counsel)
  4. Andrew D Sklawer (COO)
  5. David R Mcavoy (General Counsel)
  6. Deepak Chadha (Insider)
  7. Reginald L Hardy (Chairman)
Learn More about top insider investors at Brickell Biotech.

Who are the major institutional investors of Brickell Biotech?

Brickell Biotech's top institutional shareholders include:
  1. Millennium Management LLC — 18.89%
  2. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Brickell Biotech stock.

Which institutional investors are buying Brickell Biotech stock?

Within the previous quarter, BBI stock was acquired by institutional investors including:
  1. Millennium Management LLC
Within the last year, these company insiders have bought Brickell Biotech stock:
  1. Reginald L Hardy (Chairman)
  2. Robert Busard Brown (CEO)
  3. David R Mcavoy (General Counsel)
  4. Andrew D Sklawer (COO)
  5. David R Mcavoy (General Counsel)
  6. Deepak Chadha (Insider)
  7. Reginald L Hardy (Chairman)
Learn More investors buying Brickell Biotech stock.